Get the SPI Wire

Quoin Pharmaceuticals Ltd.

NASDAQ:QNRX
Annual Meeting

of Shareholders

MEETING DATE

11/12/2026
DEF 14A FILED
10/02/2026
PUBLISHED
10/02/2026 8:42 pm
TIME TO PUBLISH
10/04/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:QNRX · CUSIP 74907L201 · CLASS ordinary shares, no par value per share · CIK 0001671502

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

0
FOR
2
AGAINST
0
WITHHOLD
2
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
To approve a proposal to amend the beneficial ownership limitations imposed on each investor in the transaction documents entered into in connection with the Company’s private placement transactions consummated on October 14, 2025 and August 31, 2026, as applicable, to permit each such investor, upon written notice to the Company, to increase its applicable beneficial ownership limitations (including any corresponding limitations on voting power) from 4.99% to any percentage not exceeding 9.99% of the number of the Company’s outstanding Ordinary Shares (including Ordinary Shares represented by ADSs), determined immediately after giving effect to the issuance of the applicable securities, for purposes of both Section 13(d) of the Exchange Act and Section 270(5) and Section 274 of the Companies Law.
other
Elevated
Against
Board FOR · Duopoly unknown — ⚠ Divergence flagged

Filing states a group of investors could gain significant voting control of the Company.

Divergence: 1 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
To approve an adjournment of the Special Meeting to a later date, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of Proposal 1.
other
Elevated
Against
Board FOR · Duopoly unknown — ⚠ Divergence flagged

Filing states the meeting could be adjourned without voting on Proposal 1 to seek changed votes.

Divergence: 1 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

226744f53f2042fe273128578407cd28b238922a0b8e5403d67de3ce15b6dd5f

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates